Navigation Links
Corporate Affairs Role in Internal and External Relationships Key to Organizational Success
Date:11/5/2010

CHAPEL HILL, N.C., Nov. 5, 2010 /PRNewswire/ -- Corporate Affairs – also called Public Affairs – sustains internal and external relationships that are key success drivers for organizations. In many organizations, Corporate/Public Affairs is home to functions such as Government Affairs, Corporate Communications and Patient Advocacy – groups that are essential to maintaining and enhancing interactions with important external and internal partners.

Recognizing the importance these subgroups of Corporate/Public Affairs play in overall organizational success, Best Practices, LLC has published a series of reports that identify key benchmarks around structure, resources and priorities for each of these important subgroups as well as one for Corporate Affairs overall.

Listed below are the different studies examining performance excellence in each of these key groups: 

  • Corporate Affairs Excellence: Optimizing Group Structure & Operations (PSM-251)
  • Government Affairs and Public Policy Excellence: Optimizing Group Structure & Operations (PSM-252)
  • Advocacy Excellence: Optimizing Group Structure & Operations (PSM-253)
  • Communications Excellence: Optimizing Group Structure & Operations (PSM-254)

To download complimentary study excerpts for any of these reports, go to: http://www3.best-in-class.com/rr1028.htm.

Topics covered in each of these studies include:

- Group Structures and Drivers of Subgroup Evolution

- Staffing Benchmarks: Key Trends in Resourcing

- Funding Levels and Sources

- Group Services: Trends in Service Levels & Key Priorities

- Roles and Responsibilities: Trends in Alliances Management

Best Practices, LLC used both field surveys and interviews to complete these studies. The reports reflect the current state of efforts at best-in-class organizations such as Abbott, AstraZeneca, Amgen, Merck, Boehringer Ingelheim, Pfizer, Baxter, Lilly, Genentech, Novo Nordisk and others.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for 17 years; our clients include 48 out of the top 50 pharmaceutical companies. For more information visit: http://www3.best-in-class.com.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
2. Genta Incorporated Announces Third Quarter 2007 Financial Results
3. Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights
4. Shareholder Class Action Filed Against Vertex Pharmaceuticals Incorporated by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
5. Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters
6. AMT Intends to Incorporate Additional Data to its Marketing Authorization Dossier for Glybera(R)
7. Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications
8. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
9. Duska Therapeutics Completes Corporate Name Change to Cordex Pharma
10. Impact Medical Solutions Announces Appointment of New Director and Corporate Update
11. Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
(Date:9/22/2017)... ROCKVILLE, Md. , Sept. 22, 2017  As ... by Republican Senators Bill Cassidy (R-LA) and ... Kalorama Information notes that the medical device industry is ... the medical device tax, the 2.3% excise tax on ... Act.  But they also want covered patients, increased visits ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family ... next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. ... 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming the ...
(Date:10/13/2017)... ... 2017 , ... Apple Rehab Shelton Lakes , which specializes in the ... facility as part of a disaster drill on October 3rd. , Apple Rehab participated ... Emergency Manager, as well as the Connecticut Long Term Care Mutual Aid Plan ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... most popular and least understood books in the Holy Scriptures, Revelation. The Book of ... baffled scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... healthcare compliance program management, will showcase a range of technology and learning solutions ... Living (NCAL) Convention and Expo to be held October 14–18, 2017 at the ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) will ... during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual ... F. Collen, a pioneer in the field of medical informatics, this prestigious award is ...
Breaking Medicine News(10 mins):